Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric Oxide Inhalation for Cystic Fibrosis
NCT01958944Phase 2Completed
- Sponsor
- Beyond Air
- Start
- Dec 2013
- Primary completion
- Nov 2015
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of nitric oxide in cystic fibrosis (CF), sponsored by Beyond Air. Started Dec 2013; status: completed.
02
Drugs
nitric oxide
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01958944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01958944.